chr14-24369732-G-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_004554.5(NFATC4):āc.334G>Cā(p.Glu112Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,605,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. E112E) has been classified as Likely benign.
Frequency
Consequence
NM_004554.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NFATC4 | NM_004554.5 | c.334G>C | p.Glu112Gln | missense_variant | 2/10 | ENST00000250373.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NFATC4 | ENST00000250373.9 | c.334G>C | p.Glu112Gln | missense_variant | 2/10 | 1 | NM_004554.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151808Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000816 AC: 19AN: 232762Hom.: 0 AF XY: 0.0000708 AC XY: 9AN XY: 127086
GnomAD4 exome AF: 0.000144 AC: 209AN: 1454186Hom.: 0 Cov.: 38 AF XY: 0.000140 AC XY: 101AN XY: 722710
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151808Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74160
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.334G>C (p.E112Q) alteration is located in exon 2 (coding exon 2) of the NFATC4 gene. This alteration results from a G to C substitution at nucleotide position 334, causing the glutamic acid (E) at amino acid position 112 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at